BackTable Urology
Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay
Dr. Rana McKay
And I think the next generation of hormonal agents, we've got CYP11 inhibitors that now not, you know, the abiraterone is a CYP17 inhibitor, blocks a little bit lower down in the adrenal hormonal axis. You know, MK5684 is a CYP11 inhibitor that blocks even higher up. preventing cholesterol from entering into the hormone production pathway.
0
💬
0
Comments
Log in to comment.
There are no comments yet.